Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Vaccines. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel chemical synthesis method for Vibrio cholerae O100 O antigen oligosaccharide. Enhances vaccine development with high purity and scalable supply chain solutions.
Advanced chemical synthesis of Plesiomonas shigelloides O51 antigen oligosaccharides ensures high purity and scalable supply for next-generation vaccine intermediates.
New synthesis method for pseudouridine intermediate reduces costs by 30% with 82% yield. Simplified process eliminates expensive reagents and complex quenching steps for stable supply chain.